Expression of Bcl-2, PD-L1 and Its Clinical Significance in Colorectal Cancer

ZHANG Mei-yun, YANG Yong-yan, WANG Xin-hua

Abstract

To study the expression of Bcl-2 and PD-L1 in colon cancer and its relationship with metastasis. Methods Tumor samples were collected from 57 cases of colon cancer, and tumor adjacent normal mucous tissue were obtained as normal control. The expressions of Bcl-2 and PD-L1 were assayed by immunohistochemical staining, and its correlations with patients’ clinical pathological indexes were analyzed. Results The positive rate of Bcl-2 protein was 75.43% and 52.63% in colon cancer tissues and tumor adjacent colon mucous tissue respectively, with statistically significant difference (P<0.05). While the positive rate of PD-L1 was 45.61% and 15.79% in colon cancer tissues and tumor adjacent colon mucous tissue respectively, also with signficant difference (P<0.01). The positive rate of Bcl-2 was correlated with cellular differentiation, and the positive rate of PD-L1 protein was correlated with lymph node metastasis (P<0.05). Conclusion The expression of Bcl-2 may be associated with colon cancer pathologic differentiation, and the expression of PD-L1 may be associated with colon cancer metastasis.

Keywords: Bcl-2 PD-L1, Colon cancer, Clinical pathological indexes, Lymph node metastasis 


Full Text:

PDF


References


Skommer J . Brittain T. Raychaudhuri S. Bcl-2 inhibits apoptosis by increasing the time-to-death and intrinsic cell-to-cell variations in the mitochondrial pathway of cell death. Apoptosis,2010; 15(10): 1223-1233.

Czabotar PE. Lessene G. Bcl-2 family proteins as therapeutic targets. Curr Pharm Design,2010; 16(28);3132-3148.

Kudoh T, Kimura J, Lu ZG, el al. D4S234E, a novel p53- responsive gene, induces apoptosis in response to DNA damage. Exp Cell Res,2010;316( 17):2849-2858. (T859 Й)

Ghany MG, Strader DB. Thomas DL, el al. Diagnosis, management, and treatment of hepatitis C; an update. Hepatology, 2009;49(4) : 1335-1374.

Zeuzem S, Berg T, Moeller B, elal. Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepatitis,2009; 16(2) :75-90.

Hadziyannis SJ, Sette H, Morgan TR, el al. Peginterferon- alpha 2a and ribavirin combination therapy in chronic hepatitis С a randomized study of treatment duration and ribavirin dose. Ann Int Med,2004; 140(5) :346-355.

Yan KK, Guirgis M, Dinh T, el al. Treatment responses in Asians and Caucasians with chronic hepatitis С infection. World J Gastroenterol, 2008; 14 (21): 3416-3420.

Lin CK, Liu TH, Yang SH. Nonlinear position controller design with input-output linearisation technique for an interior permanent magnet synchronous motor control system. let Power Electronics,2008; 1 (1): 14-26.

Liu CH, Liu CJ, Lin CL, el al. Pegylated interferon-alpha-2a plus ribavirin for treatment-naive asian patients with hepatitis С virus genotype 1 infection; a multicenter, randomized controlled trial. Clin Infect Dis,2008;47( 10): 1260-1269.

Ge DL, Fellay J, Thompson AJ, el al. Genetic variation in IL28B predicts hepatitis С treatment-induced viral clearance. Nature,2009;461(7262):399-401.

Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis С interferon-alpha and ribavirin therapy. Nature Genetics, 2009; 41 ( 10 ): 1100-

Tanaka Y. Nishida N. Sugiyama M. et al. Genome-wide association of IL28B with response to pegylated interferon- alpha and ribavirin therapy for chronic hepatitis C. Nature Genetics.2009;41( 10): 1105-1181. 12(4): 194-198.

Urban TJ. Thompson AJ. Bradrick SS. el at. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology.2010;52(6): 1888-1896.

Sarasin-Kilipowicz M. Christen V, Duong FH, el al. Interferon regulated gene expression in the liver determines response to treatment in chronic hepatitis C. Gastroenterology. 2008; 134(4) ;A758-A758.

Montes-Cano MA. Garcia-Lozano JR. Abad-Molina С» el al. Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes. Hepatology.2010;52(1):33-37.

McCarthy JJ. Li JH, Thompson A, el al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology,2010; 138(7) :2307-2314.


Refbacks

  • There are currently no refbacks.